Interview with Egor Beketov, CEO, Biopharmaceutical investments of RVC (RVC BioFund)
02.08.2011
Related Interviews
Interview with Eric Blondeau, Managing Director, Alliance Healthcare Russia
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
Interview with Arman Voskertchyan, Managing Director, Johnson & Johnson…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
Interview with Victor Dmitriev, General Director, Association of the Russian…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
Opinion / How Can the Generics Industry Up its Game on Essential Medicine Access?
Claudia Martínez, generic & biosimilar medicines programme manager at the Access to Medicine Foundation, draws from a recent AMF report to outline what more generics companies can be doing to…
Leadership / Bill Sibold Swaps Sanofi for Biotech Seeking First NASH FDA Approval
After a 12-year stint at Sanofi, Bill Sibold is leaving Big Pharma to join the Pennsylvania-based biotech Madrigal Pharmaceuticals as CEO. Sibold, no stranger to ground-breaking launches, having brought the…
MEA / Clinical Research in the UAE: Quickfire Progress & The Road Left to Travel
With cutting-edge hospital infrastructure being put in place, government authorities rolling out evermore supportive regulatory upgrades, big pharma championing ‘clinical trial diversity’ with greater non-Caucasian representation in trial cohorts, and…
